For US Health Care Professionals Only.
Learn about pathways of disease progression in advanced hormone receptor-positive, HER2-negative breast cancer with this interactive app from Novartis Pharmaceuticals Corporation.
This app contains two resources: the Two Pathways tool and the Targeted Therapies tool.
The Two Pathways Tool:
- Learn about key pathways that drive progression in advanced hormone receptor-positive, HER2-negative breast cancer.
- Understand the interaction among pathways and crosstalk between the estrogen receptor and mTOR pathways.
The Targeted Therapies Tool:
-Challenge your knowledge of targeted therapies and their sites of action
-Better understand the effect of targeted therapies on two key pathways involved in the progression of advanced hormone-receptor positive, HER2-negative breast cancer